GRAY vs. IBIO, UPC, SBFM, ENVB, SHPH, TENX, HILS, ADXS, TRVN, and CMMB
Should you be buying Graybug Vision stock or one of its competitors? The main competitors of Graybug Vision include iBio (IBIO), Universe Pharmaceuticals (UPC), Sunshine Biopharma (SBFM), Enveric Biosciences (ENVB), Shuttle Pharmaceuticals (SHPH), Tenax Therapeutics (TENX), Hillstream BioPharma (HILS), Ayala Pharmaceuticals (ADXS), Trevena (TRVN), and Chemomab Therapeutics (CMMB). These companies are all part of the "pharmaceutical preparations" industry.
iBio (NYSE:IBIO) and Graybug Vision (NASDAQ:GRAY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, community ranking, valuation, risk and analyst recommendations.
iBio has a beta of -3.53, indicating that its share price is 453% less volatile than the S&P 500. Comparatively, Graybug Vision has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500.
iBio's return on equity of -77.61% beat Graybug Vision's return on equity.
Graybug Vision has lower revenue, but higher earnings than iBio.
Graybug Vision received 16 more outperform votes than iBio when rated by MarketBeat users. Likewise, 50.00% of users gave Graybug Vision an outperform vote while only 0.00% of users gave iBio an outperform vote.
7.9% of iBio shares are held by institutional investors. Comparatively, 49.9% of Graybug Vision shares are held by institutional investors. 1.1% of iBio shares are held by company insiders. Comparatively, 7.9% of Graybug Vision shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
In the previous week, iBio had 1 more articles in the media than Graybug Vision. MarketBeat recorded 1 mentions for iBio and 0 mentions for Graybug Vision. Graybug Vision's average media sentiment score of 0.13 beat iBio's score of 0.00 indicating that iBio is being referred to more favorably in the media.
Summary
Graybug Vision beats iBio on 7 of the 11 factors compared between the two stocks.
Get Graybug Vision News Delivered to You Automatically
Sign up to receive the latest news and ratings for GRAY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Graybug Vision Competitors List
Related Companies and Tools
